SPOTLIGHT -
Treating patients who have irregular astigmatism or decentered ablations is made easier with the advent of new technologies, according to two refractive surgeons.
Multiple companies announce data presentations at ARVO 2024
(EyePod) From idea to impact: Navigating ophthalmic innovation
Eyenovia provides clinical, scientific update on FDA-approved products Mydcombi and clobetasol propionate ophthalmic suspension
EyePod: Modifier Gene Therapy: What is it?
Gene editing untangles one strand of the AMD web
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI